The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. by Gonen-Gross, T, Achdout, H, Arnon, T, Gazit, R, Stern, N, Horejsí, V, Goldman-Wohl, D, Yagel, S, Mandelboim, O

Enhanced recognition of human NK receptors after influenza virus infection. by Achdout, H, Arnon, T, Markel, G, Gonen-Gross, T, Katz, G, Lieberman, N, Gazit, R, Joseph, A, Kedar, E, Mandelboim, O

MHC class I-independent recognition of NK-activating receptor KIR2DS4. by Katz, G, Gazit, R, Arnon, T, Gonen-Gross, T, Tarcic, G, Markel, G, Gruda, R, Achdout, H, Drize, O, Merims, S, Mandelboim, O

Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. by Gazit, R, Gruda, R, Elboim, M, Arnon, T, Katz, G, Achdout, H, Hanna, J, Qimron, U, Landau, G, Greenbaum, E, Zakay-Rones, Z, Porgador, A, Mandelboim, O

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. by Arnon, T, Achdout, H, Lieberman, N, Gazit, R, Gonen-Gross, T, Katz, G, Bar-Ilan, A, Bloushtain, N, Lev, M, Joseph, A, Kedar, E, Porgador, A, Mandelboim, O

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. by Arnon, T, Achdout, H, Levi, O, Markel, G, Saleh, N, Katz, G, Gazit, R, Gonen-Gross, T, Hanna, J, Nahari, E, Porgador, A, Honigman, A, Plachter, B, Mevorach, D, Wolf, D, Mandelboim, O

Novel APC-like properties of human NK cells directly regulate T cell activation. by Hanna, J, Gonen-Gross, T, Fitchett, J, Rowe, T, Daniels, M, Arnon, T, Gazit, R, Joseph, A, Schjetne, K, Steinle, A, Porgador, A, Mevorach, D, Goldman-Wohl, D, Yagel, S, LaBarre, M, Buckner, J, Mandelboim, O

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. by Hanna, J, Goldman-Wohl, D, Hamani, Y, Avraham, I, Greenfield, C, Natanson-Yaron, S, Prus, D, Cohen-Daniel, L, Arnon, T, Manaster, I, Gazit, R, Yutkin, V, Benharroch, D, Porgador, A, Keshet, E, Yagel, S, Mandelboim, O

Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. by Markel, G, Achdout, H, Katz, G, Ling, K, Salio, M, Gruda, R, Gazit, R, Mizrahi, S, Hanna, J, Gonen-Gross, T, Arnon, T, Lieberman, N, Stren, N, Nachmias, B, Blumberg, R, Steuer, G, Blau, H, Cerundolo, V, Mussaffi, H, Mandelboim, O